88
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients

, , , , &
Pages 6029-6038 | Published online: 22 Nov 2018

References

  • Bodner-AdlerBKimbergerOSchneidingerCKölblHBodnerKPrognostic significance of pre-treatment serum C-reactive protein level in patients with adenocarcinoma of the uterine cervixAnticancer Res20163694691469627630314
  • SmallWBaconMABajajACervical cancer: a global health crisisCancer2017123132404241228464289
  • YokoiEMabuchiSTakahashiRImpact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinomaJ Gynecol Oncol2017282e1928028992
  • RosePGAre the differences in treatment outcome for adenocarcinoma of the cervix different enough to change the treatment paradigm?Gynecol Oncol2012125228528622482933
  • WilliamsNLWernerTLJarboeEAGaffneyDKAdenocarcinoma of the cervix: should we treat it differently?Curr Oncol Rep20151741725708801
  • WrightAAHowittBEMyersAPOncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervixCancer2013119213776338324037752
  • TorneselloMLBuonaguroLBuonaguroFMMutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic reviewGynecol Oncol2013128344244823168175
  • GomezDFaridSMalikHZPreoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinomaWorld J Surg20083281757176218340479
  • HeflerLAConcinNHofstetterGSerum C-reactive protein as independent prognostic variable in patients with ovarian cancerClin Cancer Res200814371071418245530
  • JablonskaEPuzewskaWGrabowskaZJablonskiJTalarekLVEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancerCytokine2005303939915826815
  • ArdiVCKupriyanovaTADeryuginaEIQuigleyJPHuman neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesisProc Natl Acad Sci U S A200710451202622026718077379
  • Di CarloEForniGMusianiPNeutrophils in the antitumoral immune responseChem Immunol Allergy20038318220312947985
  • YinYWangJWangXPrognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysisClinics201570752453026222823
  • SugiuraTUesakaKKanemotoHMizunoTOkamuraYElevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinomaAnn Surg Oncol201320134330433723982254
  • LeeSOhSYKimSHPrognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer20131335023876227
  • JinHZhangGLiuXBlood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapyWorld J Surg Oncol20131111223705622
  • PichlerMHuttererGCStoeckigtCValidation of the pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patientsBr J Cancer2013108490190723385728
  • JankovaLDentOFChanCChapuisPClarkeSJPreoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancerBMC Cancer20131344224079717
  • DingPRAnXZhangRXElevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancerInt J Colorectal Dis201025121427143320821217
  • GalonJCostesASanchez-CaboFType, density, and location of immune cells within human colorectal tumors predict clinical outcomeScience200631357951960196417008531
  • JungEJByunJMKimYNCervical adenocarcinoma has a poorer prognosis and a higher propensity for distant recurrence than squamous cell carcinomaInt J Gynecol Cancer20172761228123628604449
  • GalicVHerzogTJLewinSNPrognostic significance of adenocarcinoma histology in women with cervical cancerGynecol Oncol2012125228729122266551
  • KotowiczBKaminskaJFuksiewiczMClinical significance of serum CA-125 and soluble tumor necrosis factor receptor type I in cervical adenocarcinoma patientsInt J Gynecol Cancer201020458859220686378
  • MosesKBrandauSHuman neutrophils: Their role in cancer and relation to myeloid-derived suppressor cellsSemin Immunol201628218719627067179
  • LeeYYChoiCHKimHJPretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinomaAnticancer Res20123241555156122493401
  • ProctorMJMcMillanDCMorrisonDSFletcherCDHorganPGClarkeSJA derived neutrophil to lymphocyte ratio predicts survival in patients with cancerBr J Cancer2012107469569922828611
  • WangLJiaJLinLPredictive value of hematological markers of systemic inflammation for managing cervical cancerOncotarget2017827448244483228148894
  • ZhangYWangLLiuYPreoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgeryInt J Gynecol Cancer20142471319132525033256
  • MizunumaMYokoyamaYFutagamiMAokiMTakaiYMizunumaHThe pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancerInt J Clin Oncol201520598999625736530
  • HuangQTManQQHuJPrognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studiesOncotarget2017810167551676428187430
  • TempletonAJMcNamaraMGŠerugaBPrognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisJ Natl Cancer Inst20141066dju12424875653
  • ChoYKimKHYoonHIKimGEKimYBTumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patientsAnn Oncol201627112067207427502717
  • WangDWuMFengFZPretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomyChin Med J201312681464146823595378
  • KoseMCelikFKoseSKAriozDTYilmazerMCould the platelet-to-lymphocyte ratio be a novel marker for predicting invasiveness of cervical pathologies?Asian Pac J Cancer Prev201516392392625735383
  • SmithRABosonnetLGhanehPThe platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancerSurgery2008143565866618436014
  • AcmazGAksoyHUnalDAre neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding?Asian Pac J Cancer Prev20141541689169224641391
  • KozasaKMabuchiSKomuraNComparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature reviewOncotarget2017833553945540428903428
  • ChenLZhangFShengXGZhangSQChenYTLiuBWPeripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: LymphocyteMedicine20169532e438127512849
  • NakamuraKNishidaTHarumaTPretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapyMol Clin Oncol2015351001100626623040
  • SpragueBLTrentham-DietzAKleinBEPhysical activity, white blood cell count, and lung cancer risk in a prospective cohort studyCancer Epidemiol Biomarkers Prev200817102714272218843014
  • Tavares-MurtaBMMendonçaMADuarteNLSystemic leukocyte alterations are associated with invasive uterine cervical cancerInt J Gynecol Cancer20102071154115921495217
  • HaragaJNakamuraKOmichiCPretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapyMol Clin Oncol20165556757427900086
  • GelbandHSankaranarayananRGauvreauCLCosts, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd editionLancet2016387100332133214426578033
  • OnalCGulerOCYildirimBAPrognostic Use of pretreatment hematologic parameters in patients receiving definitive chemoradiotherapy for cervical cancerInt J Gynecol Cancer20162661169117527206286
  • WangYYBaiZLHeJLPrognostic value of neutrophil-related factors in locally advanced cervical squamous cell carcinoma patients treated with cisplatin-based concurrent chemoradiotherapyDis Markers2016201619
  • ZhengRRHuangMJinCCervical cancer systemic inflammation score: a novel predictor of prognosisOncotarget2016712152301524226885692
  • MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
  • BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
  • ParamanathanASaxenaAMorrisDLA systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumoursSurg Oncol2014231313924378193